RFC
ICPT

Russell Frank Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Russell Frank Company’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$704K Buy
5,481
+1,818
+50% +$215K ﹤0.01% 2313
2015
Q4 		$550K Buy
3,663
+147
+4% +$24.9K ﹤0.01% 2464
2015
Q3 		$583K Buy
3,516
+563
+19% +$124K ﹤0.01% 2429
2015
Q2 		$713K Sell
2,953
-32,284
-92% -$8.6M ﹤0.01% 2463
2015
Q1 		$9.94M Sell
35,237
-65,517
-65% -$14.2M 0.02% 874
2014
Q4 		$15.7M Buy
100,754
+20,794
+26% +$3.84M 0.03% 679
2014
Q3 		$18.9M Buy
79,960
+33,150
+71% +$8.45M 0.03% 574
2014
Q2 		$10.9M Buy
46,810
+24,265
+108% +$6.4M 0.02% 865
2014
Q1 		$6.33M Buy
22,545
+2,003
+10% +$676K 0.01% 1149
2013
Q4 		$5.63M Sell
20,542
-507
-2% -$29.3K 0.01% 1160
2013
Q3 		$1.45M Buy
+21,049
New +$1.04M ﹤0.01% 2011

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's ICPT Position: Q1 2016 in Review

Russell Frank Company increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 50% in Q1 2016, buying an estimated $215K and bringing the position to 5,481 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

Russell Frank Company first reported a position in ICPT in Q3 2013 and has held it in 11 quarters since. The position peaked at $18.9M in Q3 2014. 160 funds tracked by Wall St. Rank hold ICPT as of Q1 2016.

  • Russell Frank Company held 5,481 shares of Intercept Pharmaceuticals, Inc. worth $704K as of Q1 2016.
  • Russell Frank Company bought 1,818 Intercept Pharmaceuticals, Inc. shares in Q1 2016, an estimated $215K.
  • Intercept Pharmaceuticals, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2313 holding.
  • Russell Frank Company first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and has held it in 11 quarters since.
  • Russell Frank Company's Intercept Pharmaceuticals, Inc. position peaked at $18.9M in Q3 2014.
  • 160 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.